Levetiracetam Aristo

Levetiracetam, the active ingredient in Levetiracetam Aristo, is an antiepileptic presented as an oral tablet for oral use. It is prescribed to control partial, generalized tonic‑clonic and myoclonic seizures in patients diagnosed with epilepsy, and is suitable for both adult and pediatric populations under medical supervision.

GNH USA supplies Levetiracetam Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global healthcare providers, including bulk shipments and customized packaging to meet local requirements.

Levetiracetam is used in the management of epileptic seizure disorders, targeting neuronal hyper‑excitability.

Partial seizures: reduces the frequency and severity of focal onset seizures, improving daily functioning and lowering injury risk. Generalized tonic‑clonic seizures: helps prevent convulsive episodes in patients with generalized epilepsy, supporting better seizure control. Myoclonic seizures: diminishes sudden muscle jerks associated with juvenile myoclonic epilepsy, enhancing quality of life.

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and clinical significance.

Common Side Effects: - Dizziness - Somnolence - Headache - Fatigue - Nausea - Irritability

Serious or Rare Side Effects: - Severe psychiatric reactions such as depression or suicidal ideation - Allergic skin reactions, including Stevens‑Johnson syndrome - Rash or hypersensitivity reactions - Blood dyscrasias (e.g., leukopenia, thrombocytopenia)

Levetiracetam requires careful consideration of patient‑specific factors and handling conditions. - Renal impairment: dose adjustment may be needed based on creatinine clearance. - Pregnancy: category B; use only when benefit outweighs potential risk. - Psychiatric history: monitor for mood changes or emergent suicidal thoughts. - Concomitant CNS depressants: may increase sedation. - Alcohol: avoid excessive consumption as it can enhance central nervous system effects. - Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Levetiracetam can interact with several medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Live vaccines: may reduce vaccine efficacy; avoid co‑administration. - Strong enzyme inducers (e.g., carbamazepine, phenytoin): can lower levetiracetam plasma levels. - Alcohol dependence: increased risk of central nervous system depression.

Moderate Interactions (Monitor Closely): - Other antiepileptics (e.g., valproate, lamotrigine): may require dose adjustments. - Sedatives or hypnotics: additive sedation may occur. - Renal excretion modifiers (e.g., probenecid): may affect drug clearance.